Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Inclusion in research: strategies to tackle implicit barriers for older people

Bowie’s article rightly highlights that people aged over 75 remain disproportionately under-represented in research, despite the ageing population.1 […]

February 4, 2026 Uncategorized

Most cancers are not caused by lifestyle but four in 10 could be prevented, WHO study finds

Most new cancer cases are not caused by modifiable risk factors such as tobacco and alcohol, but nearly […]

February 4, 2026 Oncology, General practice / family medicine

When AI hears suicidal intent: rethinking the duty of care

OpenAI’s finding that, each week, hundreds of thousands of ChatGPT users express signs of mental distress, including suicidal […]

February 4, 2026 Uncategorized

Why heart disease risk in type 2 diabetes looks different for men and women

Scientists are digging into why heart disease risk in type 2 diabetes differs between men and women—and sex […]

February 4, 2026 Uncategorized

Managing delirium: moving beyond a single cause mindset

Stokel-Walker correctly highlights that, despite its prevalence and serious consequences, delirium remains under-recognised and poorly managed.1 One reason […]

February 4, 2026 Uncategorized

RAPIDOX BASE (sodium chlorite) solution, concentrate [DeLaval]

Updated Date: Tue, 27 Jan 2026 00:00:00 EST

February 4, 2026 Uncategorized

Resident doctors in England vote for six months more industrial action

Resident doctors in England have voted overwhelmingly to extend their mandate for strike action over pay and jobs […]

February 4, 2026 Uncategorized

RFK Jr names anti-vaccine members to federal autism committee

Robert F Kennedy Jr’s “cherrypicked” appointees to a federal autism committee have sparked alarm among autism advocates and […]

February 4, 2026 Uncategorized

Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay

Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
p p Read More

The company will initially develop a vaccine to tackle colorectal and pancreatic cancers

February 3, 2026 Gustave Roussy, Kahimmune Therapeutics, News, Oncology, SATT Paris-Saclay

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease

IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
p p Read More

Perovial is the first ever hyaluronic acid injectable treatment to be licensed for acute Peyronie’s disease

February 3, 2026 IBSA, News, Peyronie's disease

Posts navigation

« Previous

Posts pagination

1 2 … 1,942 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy